Tampere University has licensed a drug molecule intended for treating Epidermolysis Bullosa (EB), a group of rare and severe skin disorders, to Theravia, a pharmaceutical company headquartered in the ...
Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® ...
Merck (MRK) stock in focus as anti-cancer agent Welireg is approved in the EU for kidney tumor conditions, VHL disease and ...
The EU regulates the authorisation of medicines at EU level by the European Medicines Agency or at national level by the competent authorities in EU countries. Special rules exist for the ...
A comprehensive strategy that combines pharmacological advances, vector control, public outreach to raise awareness and ...
The flight was the first in Europe to take place in upper airspace. It was conducted as part of a research project by the European Defence Agency (EDA), which aims to help enable remotely-piloted, ...
Bluesky is becoming a hub for legal industry conversations that once thrived on Twitter/X but have largely disappeared. By emphasizing transparency and user control, Bluesky offers a refreshing ...
Sky News contributor Kosha Gada reacts to former US president Joe Biden signing with a major talent agency as “so absurd”. “It is odd because on the face of it, it’s so absurd and we all ...
On 20 December 2021, the EU authorised the first protein-based vaccine (produced by Novavax) for use in the EU, following a positive recommendation of the European Medicines Agency. The Novavax ...
David joined Raw Story in 2023 after nearly a decade of writing about the legal industry for Bloomberg Law. He is also a co-founder and a commissioning editor at Hypatia Press, a publisher that ...
The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on the social media platform X, opting instead to utilize a rival platform Bluesky for its social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results